US FDA approves AbbVie’s oral JAK inhibitor, Rinvoq to treat rheumatoid arthritis

Additional findings were announced from a phase 2/3 study evaluating the efficacy and safety of Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) in patients with COVID-19 who are at standard risk of...

Reactie op de consultatie van de Europese Commissie over het vergoedingensysteem van het Europees Geneesmiddelenagentschap (EMA).
Dit document is in het Engels.

All eyes in oncology were focused expectantly last week on the tranche of clinical data that trickled out in advance of the sector’s largest and most meaningful meeting. But abstracts from the American Society of...